MyFinsight
Home
Blog
About
Contact
Download
Download image
Spinraza Royalties
$43,710K
Wainus Royalties
$10,709K
Other Royalties
$3,904K
Net loss
-$92,528K
(37.03%↑ Y/Y)
Collaborative Agreement
Revenue
$120,660K
Wainua Joint
Development Revenue
$17,621K
Royalty
$58,323K
Product
$42,955K
Other Commercial
$6,532K
Loss before income
tax expense
-$92,310K
(37.13%↑ Y/Y)
Income tax expense
$218K
(87.93%↑ Y/Y)
Investment income
$25,484K
(3.31%↑ Y/Y)
Research And Development
Revenue
$138,281K
Commercial
$107,810K
Gain (loss) on
investments, net
$22,583K
(1143.58%↑ Y/Y)
Loss from operations
-$117,424K
(20.04%↑ Y/Y)
Revenue
$246,091K
Interest expense related
to sale of future...
$17,337K
(-7.89%↓ Y/Y)
Interest expense
$5,160K
(25.61%↑ Y/Y)
Other income
(expense), net
-$456K
(-198.06%↓ Y/Y)
Total operating
expenses
$363,515K
Research, development and
patent
$210,173K
Selling, general and
administrative
$150,359K
Cost of sales
$2,983K
Back
Back
Income Statement
IONIS PHARMACEUTICALS INC (IONS)
IONIS PHARMACEUTICALS INC (IONS)
source: myfinsight.com